Genetic Net Income from 2010 to 2025

Stocks . Australia . 
Stock . Genetic Signatures
GSS Stock   0.24  0.00  0.00%   
Genetic Signatures Net Loss yearly trend continues to be comparatively stable with very little volatility. Net Loss is likely to outpace its year average in 2025. From the period from 2010 to 2025, Genetic Signatures Net Loss quarterly data regression had r-value of (0.66) and coefficient of variation of (131.44). View All Fundamentals
 
Net Loss  
First Reported
2012-12-31
Previous Quarter
-15.2 M
Current Value
-4.9 M
Quarterly Volatility
3.4 M
 
Yuan Drop
 
Covid
Check Genetic Signatures financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Genetic Signatures' main balance sheet or income statement drivers, such as Interest Expense of 95.5 K, Selling General Administrative of 16.9 M or Total Revenue of 11 M, as well as many indicators such as . Genetic financial statements analysis is a perfect complement when working with Genetic Signatures Valuation or Volatility modules.
  
This module can also supplement various Genetic Signatures Technical models . Check out the analysis of Genetic Signatures Correlation against competitors.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Genetic Stock Analysis

When running Genetic Signatures' price analysis, check to measure Genetic Signatures' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genetic Signatures is operating at the current time. Most of Genetic Signatures' value examination focuses on studying past and present price action to predict the probability of Genetic Signatures' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genetic Signatures' price. Additionally, you may evaluate how the addition of Genetic Signatures to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2025 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY